Clinical Focus
Previous Articles Next Articles
Online:
Published:
Contact:
Abstract: Objective To investigate the clinical value of serum thymidine kinase 1 (STK1), thyroglobulin (Tg) and thyroid transfer factor 1 (TTF1) in the differential diagnosis of benign and malignant thyroid nodules. Methods From January 2016 to January 2018, 95 patients with malignant thyroid nodules were enrolled as malignant nodules group. 45 patients with benign thyroid nodules and 30 healthy subjects were selected in our hospital as benign nodule group and healthy control group. Serum levels of STK1, Tg and TTF1 were detected by enzymelinked immunosorbent assay. The changes of serum STK1, Tg and TTF1 levels in malignant nodules group, benign nodule group and healthy control group, and the relationship between serum STK1, Tg and TTF1 levels and thyroid TNM staging in malignant nodules and the clinical value of serum STK1, Tg and TTF1 levels were observed to identify the clinical value of benign and malignant thyroid nodules.Results The levels of STK1, Tg and TTF1 in the malignant nodules group were significantly higher than those in the benign nodules group and the healthy control group (P<0.01). The TTF1 level in the benign nodule group was significantly higher than that in the healthy control group (P<0.01), and the levels of STK1 and Tg in the benign nodule group were not significantly different from those in the healthy control group (P>0.05). The levels of serum STK1, Tg and TTF1 in patients with thyroid malignant nodules increased with the increase of tumor stage (P<0.01).Serum STK1 levels in patients with thyroid malignant nodules were positively correlated with Tg (r=0.816, P<0.01) and TTF1 (r=0.753, P<0.01), while Tg levels were positively correlated with TTF1 levels (r=0.687, P<0.01). The combined detection of STK1, Tg and TTF1 was used as the test variable, and the ROC curve was drawn with the occurrence of thyroid malignancy as the state variable. The optimal cutoff value for joint detection in the diagnosis of thyroid malignancy was >0.193, and its sensitivity was 91.6%. The specificity was 92.6%, and the area under the combined detection curve was 0.960, which was significantly better than STK1 (Z=3.031, P<0.01), Tg(Z=4.477, P<0.01) and TTF1 (Z=4.483, P<0.01), and the area under the curve of STK1, Tg and TTF1 was not statistically significant (P>0.05).Conclusion STK1, Tg and TTF1 are closely related to the malignant degree of malignant thyroid nodules. The combined detection of three markers has high sensitivity and specificity for the differential diagnosis of benign and malignant thyroid nodules.
Key words: thymidine kinase, thyroglobulin, diagnosis, differential , thyroid nodule
Tang Chenghui, Li Xueqing. Diagnostic value of serum thymidine kinase 1, thyroglobulin and thyroid transfer factor1 in benign and malignant thyroid nodules[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2019.02.009.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2019.02.009
https://huicui.hebmu.edu.cn/EN/Y2019/V34/I2/136